Updates

DiscoverIE

March 2021

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

A positive Q3 update from DiscoverIE, with guidance for profit for the year to end March to be at the ‘upper end of expectations.’ Sales from D&M now make up 67% of revenue. Orders continue to be ahead of sales with the order book at £162m, a 16% increase from H1. The book to bill ratio was 1.2:1, a significant improvement on H1. Net debt at end H1 was £42m against a facility of £240m, which leaves scope for M&A. Jefferies forecasts eps of 23.1p for the year ending this month, followed by 26p. Strong hold. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Manolete

Dunelm

DiscoverIE (July 2024)

DiscoverIE - 15 deals in live negotiation (January 2024)

DiscoverIE (May 2023)

DiscoverIE (December 2022)

DiscoverIE (July 2022)

DiscoverIE - Trading ahead of expectations (May 2022)

DiscoverIE (October 2021)

DiscoverIE (July 2021)

DiscoverIE (September 2020)

DiscoverIE (May 2020)

DiscoverIE - Latest acquisition has 35%+ margins (November 2019)

DiscoverIE (May 2018)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X